Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
AI is transforming biologic wound care through earlier diagnosis, better healing predictions, improved therapy selection, and faster clinical research.
-
MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and...
-
Austin, TX, USA, July 22, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Botulinum Toxin in Urology Market Size, Trends and Insights By Product Type...
-
Vivasor Appoints JP3E Development as Exclusive Strategic Representative in the Republic of Korea
-
Austin, TX, USA, July 22, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “AI in Drug Repurposing Market Size, Trends and Insights By Component (Software...
-
Analyzes market dynamics, competitive developments, patent and regional opportunities shaping the future of substance use disorder treatment worldwide.
-
FDA endorses key elements of Arletta Pharma's Phase 2 study of Lybrido, a dual-action therapy for women with FSIAD/HSDD, and opens path to a single Phase 3
-
Persephoni Backs SelSym Biotech to Bring Blood-Type-Agnostic Bleeding Control to the Point of Injury
Persephoni backs SelSym Biotech to bring the first shelf-stable, blood-type agnostic hemostatic therapy to the point of injury, expanding trauma access.
-
AscellaHealth Named ACAP Preferred Vendor to Advance Specialty Pharmacy Strategy, Cost Containment and Care Management
-
Results presented by the LiBBY study team at the Alzheimer’s Association International Conference (“AAIC”) demonstrated statistically significant improvements in agitation symptoms compared with...